0000000000421226

AUTHOR

Mariani G.

Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT

research product

Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial

research product

Coagulation and clinical features associated with the Arg304Gln mutation (Factor VII Padua) in the IRF7 Study Group

research product

Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial

research product

Gastrointestinal bleeding in patients with von Willebrand disease; how long we can wait for surgery?

research product